Sage Therapeutics to Present at 2019 Wedbush PacGrow Healthcare Conference
06 August 2019 - 6:30AM
Business Wire
Sage Therapeutics (NASDAQ:SAGE), a biopharmaceutical company
committed to developing novel therapies with the potential to
transform the lives of people with debilitating disorders of the
brain, today announced that the Company will participate in the
2019 Wedbush PacGrow Healthcare Conference on Tuesday, August 13,
2019, in New York, NY.
Steve Kanes, M.D., chief medical officer of Sage, will be a
featured speaker on the panel, Overcoming Challenges in CNS Drug
Development, at 11:30 a.m. EDT.
A live webcast of the panel can be accessed on the investor page
of Sage's website at investor.sagerx.com. A replay of the webcast
will also be archived for up to 30 days on Sage's website following
the conference.
About Sage Therapeutics Sage Therapeutics is a
biopharmaceutical company committed to developing novel therapies
with the potential to transform the lives of people with
debilitating disorders of the brain. We are pursuing new pathways
with the goal of improving brain health and our depression,
neurology and neuropsychiatry franchise programs aim to change how
brain disorders are thought about and treated. Our mission is to
make medicines that matter so people can get better, sooner. For
more information, please visit www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190805005628/en/
Investor Contact Maren Killackey 617-949-4113
maren.killackey@sagerx.com
Media Contact Alexis Smith 617-588-3740
alexis.smith@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Apr 2024 to May 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From May 2023 to May 2024